Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

Tenth Mandatory Redemption

4 Apr 2022 07:00

RNS Number : 9430G
JPEL Private Equity Limited
04 April 2022
 

JPEL Private Equity Limited

Ground Floor

Cambridge House

Le Truchot, St Peter Port

Guernsey, GY1 1WD

www.jpelonline.com

 

 

JPEL ANNOUNCES TENTH MANDATORY REDEMPTION TO US$ SHAREHOLDERS

 

 

 

· JPEL WILL RETURN $18 MILLION TO SHAREHOLDERS

 

· REDEMPTION DATE 8 APRIL 2022

 

· REDEMPTION REPRESENTS 24.3% OF US$ EQUITY SHAREHOLDER NET ASSET VALUE AT 31 DECEMBER 2021

 

* * *

 

GUERNSEY, 4 APRIL 2022

 

 

The Company has resolved to return a total of $18 million to JPEL US$ Equity Shareholders. Redemption proceeds will be comprised of existing cash on JPEL's balance sheet.

 

The $18 million capital return (the equivalent of approximately 9.7 million US$ Equity Shares, or approximately 24.3% of US$ Equity Shareholder NAV) will be by way of a pro rata compulsory redemption of US$ Equity Shares at a price equal to the prevailing NAV per US$ Equity Share of $1.85 as at 31 December 2021 (being the most recent NAV per US$ Equity Share available as of the date of this announcement) for US$ Equity Shareholders on the register of members as at close of business on 8 April 2022 ("Record Date"). Unless circumstances require otherwise, this NAV will form the NAV per US$ Equity Share as of the date of redemption.

 

Payments of redemption proceeds are expected to be effected either through CREST (in the case of shares held in uncertificated form) or by cheque (in the case of shares held in certificated form) on or around 21 April 2022. Any share certificates for the balance of holdings of shares will also be despatched to shareholders on or 20 April 2022.

 

The Company currently has 40,017,883 US$ Equity Shares in issue. All of the US$ Equity Shares redeemed on the redemption date will be cancelled and any fractions of shares will be rounded down to the nearest whole share.

 

The US$ Equity Shares will be disabled in CREST on the Record Date and the existing ISIN number GG00BM8B8T38 (the "Old ISIN") will expire. A new ISIN number GG00BMFD2F62 (the "New ISIN") in respect of the remaining US$ Equity Shares which have not been redeemed will be enabled and available for transactions on 11 April 2022. For the period up to and including the Record date, US$ Equity Shares will be traded under the Old ISIN and as such, a purchaser of such shares may have a market claim for the redemption proceeds following the activation of the New ISIN. CREST will automatically transfer any open transactions as at the redemption date to the New ISIN.

 

Inclusive of this Mandatory Redemption, JPEL will have returned $517.2 million to US$ Equity Shareholders, or approximately 108% and 136% of the Company's 31 October 2016 NAV and market capitalization. Please note that the prevailing NAV at the time of the Company's first mandatory redemption was 31 October 2016.

 

 

DIRECTOR'S INTERESTS

 

As of 5 August 2021, Sean Hurst, Christopher Spencer and Tony Dalwood, Directors of the Company, owned 2,953, 3,563 and 15,133 US$ Equity Shares, respectively. As a result of the Mandatory Redemption described above, Sean Hurst, Christopher Spencer and Tony Dalwood are expected, immediately following the redemption date, to hold approximately 2,234, 2,695 and 11,444 US$ Equity Shares, respectively.

 

 

* * *

 

 

LEI Number: 5493005M6GBE3DNJZ894

 

 

 

 

About JPEL Private Equity Limited

 

JPEL Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well-diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

 

ENQUIRIES:

 

FCF JPEL Management LLC

JPELClientService@fortress.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CASVFLBBLZLXBBQ
Date   Source Headline
18th Nov 20207:00 amRNSStatement re Company Update
13th Nov 20202:49 pmRNSNet Asset Value - August 2020
9th Nov 20204:43 pmRNSNet Asset Value - July 2020
4th Nov 20209:35 amRNS2020 AGM CIRCULAR
8th Oct 20207:00 amRNSAnnual Financial Report - 30 June 2020
16th Sep 202011:55 amRNSNet Asset Value - June 2020
31st Jul 20203:05 pmRNSNet Asset Value - May 2020
24th Jun 20207:00 amRNSNet Asset Value - April 2020
10th Jun 202011:04 amRNSNet Asset Value - March 2020
24th Apr 20207:00 amRNSNet Asset Value - February 2020
14th Apr 20204:47 pmRNSNet Asset Value - January 2020
14th Apr 20203:35 pmRNSNet Asset Value - January 2020
14th Apr 20203:16 pmRNSHolding(s) in Company
1st Apr 20205:35 pmRNSReplacement Completion of 7th Mandatory Redemption
1st Apr 20203:33 pmRNSCompletion of Seventh Mandatory Redemption
25th Mar 20207:00 amRNSSeventh Mandatory Redemption
17th Mar 20203:46 pmRNSHalf-year Report - 31 December 2019
13th Mar 20207:00 amRNSPartial Sale of 2nd Largest Investment
6th Mar 20204:51 pmRNSNet Asset Value(s) - December 2019
10th Jan 20203:21 pmRNSNet Asset Value - November 2019
5th Dec 20194:56 pmRNSNet Asset Value(s) - October 2019
26th Nov 20197:00 amRNSAGM Results 2019
15th Nov 20196:23 pmRNSNet Asset Value(s) - September - Replacement
15th Nov 20195:52 pmRNSNet Asset Value(s) - September
15th Nov 20195:51 pmRNSNet Asset Value(s) - August 2019
15th Nov 20195:51 pmRNSNet Asset Value(s) - July 2019
5th Nov 20195:42 pmRNS2019 AGM CIRCULAR
22nd Oct 20197:00 amRNSCompletion of Sixth Mandatory Redemption
9th Oct 20193:28 pmRNSSixth Mandatory Redemption
27th Sep 201910:48 amRNSAnnual Financial Report - 30 June 2019
10th Sep 20191:19 pmRNSNet Asset Value(s) - June 2019
12th Jul 20197:00 amRNSNet Asset Value(s) - May 2019
13th Jun 20197:00 amRNSNet Asset Value(s) - April 2019
17th May 20197:00 amRNSNet Asset Value(s) - March 2019
5th Apr 20197:00 amRNSNet Asset Value(s) - February 2019
19th Mar 20193:57 pmRNSHalf-year Report - 31 December 2018
13th Mar 20197:00 amRNSNet Asset Value(s)
7th Feb 201910:55 amRNSNet Asset Value(s) - December 2018
22nd Jan 201910:10 amRNSNet Asset Value(s) - November 2018
8th Jan 20197:00 amRNSCompletion Of Fifth Mandatory Redemption
10th Dec 20183:58 pmRNSMandatory Redemption - US$Equity Shares - Dec 2018
6th Dec 20183:28 pmRNSHolding(s) in Company
30th Nov 20183:21 pmRNSNet Asset Value(s) - October 2018
27th Nov 201811:08 amRNSAGM Results 2018
7th Nov 20187:00 amRNS2018 AGM CIRCULAR
30th Oct 20187:00 amRNSNet Asset Value(s) - August 2018
30th Oct 20187:00 amRNSNet Asset Value(s) - July 2018
30th Oct 20187:00 amRNSNet Asset Value(s) - September 2018
12th Oct 20184:32 pmRNSHolding(s) in Company
4th Oct 20182:42 pmRNSNotification of Dealings in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.